Subpath analysis of each subtype of head and neck cancer based on the regulatory relationship between miRNAs and biological pathways

Oncology Reports

Volumn 34, Issue 4, 2015, Pages 1745-1754

  An, Fengwei ^a   Zhang, Zhiqiang ^b   Xia, Ming ^c   Xing, Lijun ^d  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b The People's Hospital of Huangdao District   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^d People's Hospital of Rushan City   (China)

Author keywords

Biological pathway; Differentially expressed genes; Head and neck squamous cell carcinoma; MiRNA; Subpath

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 144; MICRORNA 153; MICRORNA 200B; MICRORNA 200C; MICRORNA 206; MICRORNA 26A; MICRORNA 27A; MICRORNA 27B; MICRORNA 29A; MICRORNA 329; MICRORNA 34B; MICRORNA 409 3P; MICRORNA 429; MICRORNA 505; MICRORNA 506; MICRORNA 506A; MICRORNA 519A; MICRORNA 524; MICRORNA 9; MICRORNA 98; MICRORNA LET 7A; UNCLASSIFIED DRUG; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BPNT1 GENE; CANCER CLASSIFICATION; CANCER GENETICS; COL5A1 GENE; CYP46A1 GENE; DISEASE ASSOCIATION; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC SCREENING; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; MCM7 GENE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; WART VIRUS; BIOSYNTHESIS; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICRORNAS; NEOPLASM PROTEINS;

EID: 84939162483     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4150     Document Type: Article

References (55)

1. Argiris A, Karamouzis MV, Raben D and Ferris RL: Head and neck cancer. Lancet 371: 1695-1709, 2008.
2. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18: 541-550, 2009.
3. østhus AA, Aarstad AKH, Olofsson J and Aarstad HJ: Prediction of 5 year survival from level of perceived distress in newly diagnosed head and neck squamous cell carcinoma patients. Oral Oncol 49: 964-969, 2013.
4. Datema FR, Poldermans D and Baatenburg de Jong RJ: Incidence and prediction of major cardiovascular complications in head and neck surgery. Head Neck 32: 1485-1493, 2010.
5. López RV, Zago MA, Eluf-Neto J, Curado MP, Daudt AW, da Silva-Junior WA, Zanette DL, Levi JE, de Carvalho MB, Kowalski LP, et al: Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer. Braz J Med Biol Res 44: 1006-1012, 2011.
6. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J and Anderson LA: Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis. Oral Oncol 48: 1191-1201, 2012.
7. Moral M and Paramio JM: Akt pathway as a target for therapeutic intervention in HNSCC. Histol Histopathol 23: 1269-1278, 2008.
8. Nieh S, Jao SW, Yang CY, Lin YS, Tseng YH, Liu CL, Lee TY, Liu TY, Chu YH and Chen SF: Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma. Head Neck: July 2, 2014 (Epub ahead of print).
9. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D and Califano JA: microRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797, 2008.
10. Liu X, Jiang L, Wang A, Yu J, Shi F and Zhou X: microRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286: 217-222, 2009.
11. Wanebo HJ, Lee J, Burtness BA, Ridge J A, Ghebremichael M, Spencer SA, Psyrri D, Pectasides E, Rimm D, Rosen FR, et al: Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: A phase II ECOG-ACRIN trial (E2303). Ann Oncol 25: 2036-2041, 2014.
12. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, et al: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5: 489-500, 2004.
13. Kim KY, Zhang X and Cha IH: Identification of human papillomavirus status specific biomarker in head and neck cancer. Head Neck: May 11, 2014 (Epub ahead of print).
14. Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et al: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci 61: 1372-1383, 2004.
15. Pruitt KD, Tatusova T and Maglott DR: NCBI Reference Sequence (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 33: D501-D504, 2005.
16. Walter V, Yin X, Wilkerson MD, Cabanski CR, Zhao N, Du Y, Ang MK, Hayward MC, Salazar AH, Hoadley KA, et al: Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One 8: e56823, 2013.
17. Catanzaro B, Garland M and Keutzer K: Copperhead: Compiling an embedded data parallel language. In: Proc. 16th ACM Symposium on Principles and Practice of Parallel Programming, PPoPP '11, ACM, NY, pp47-56, 2011. doi: http://doi.acm. org/10.1145/1941553.1941562.
18. de Ronde JJ, Rigaill G, Rottenberg S, Rodenhuis S and Wessels LF: Identifying subgroup markers in heterogeneous populations. Nucleic Acids Res 41: e200, 2013.
19. Reimers M and Carey VJ: Bioconductor: An open source framework for bioinformatics and computational biology. Methods Enzymol 411: 119-134, 2006.
20. Yu T and Peng H: Hierarchical clustering of high throughput expression data based on general dependences. IEEE/ACM Trans Comput Biol Bioinformatics 10: 1080-1085, 2013.
21. Guttula SV, Allam A and Gumpeny RS: Analyzing microarray data of Alzheimer's using cluster analysis to identify the biomarker genes. Int J Alzheimers Dis 2012: 649456, 2012.
22. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P and Mesirov JP: Molecular signatures database (MSigDB) 3.0. Bioinformatics 27: 1739-1740, 2011.
23. Hong G, Zhang W, Li H, Shen X and Guo Z: Separate enrichment analysis of pathways for up-and downregulated genes. J R Soc Interface 11: 20130950, 2014.
24. Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I, Preuss SF, Straetmans JM, et al: Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15: 1779-1786, 2009.
25. Michaud DS, Langevin SM, Eliot M, Nelson HH, Pawlita M, McClean MD and Kelsey KT: High-risk HPV types and head and neck cancer. Int J Cancer 135: 1653-1661, 2014.
26. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A and Gillison ML: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269, 2008.
27. Ohyama Y, Meaney S, Heverin M, Ekström L, Brafman A, Shafir M, Andersson U, Olin M, Eggertsen G, Diczfalusy U, et al: Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): Marked insensitivity toward different regulatory axes. J Biol Chem 281: 3810-3820, 2006.
28. Chiang JY: Bile acids: Regulation of synthesis. J Lipid Res 50: 1955-1966, 2009.
29. McMichael AJ and Potter JD: Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 75: 185-191, 1985.
30. Gupta S, Stravitz RT, Dent P and Hylemon PB: Down-regulation of cholesterol 7-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem 276: 15816-15822, 2001.
31. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF and Yang MY: Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 33: 1933-1942, 2012.
32. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
33. Yu CC, Chen YW, Chiou GY, Tsai LL, Huang PI, Chang CY, Tseng LM, Chiou SH, Yen SH, Chou MY, et al: MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 47: 202-210, 2011.
34. Zhang T, Liu M, Wang C, Lin C, Sun Y and Jin D: Down-regulation of MIR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 31: 3859-3863, 2011.
35. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A and Wennerberg J : Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83: 775-781, 2000.
36. Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, et al: MIR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2: 29-42, 2011.
37. Xu Q, Sun Q, Zhang J, Yu J, Chen W and Zhang Z: Downregulation of MIR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 34: 539-549, 2012.
38. Tong X, Zhao F and Thompson CB: The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 19: 32-37, 2009.
39. Cunningham JT, M oreno M V, L odi A, R onen S M a nd Ruggero D: Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell 157: 1088-1103, 2014.
40. Quiroz JA, Gould TD and Manji HK: Molecular effects of lithium. Mol Interv 4: 259-272, 2004.
41. Spiegelberg BD, Xiong JP, Smith JJ, Gu RF and York J D: Cloning and characterization of a mammalian lithium-sensitive bisphosphate 3'-nucleotidase inhibited by inositol 1,4-bisphosphate. J Biol Chem 274: 13619-13628, 1999.
42. Arora H, Qureshi R and Park W-Y: MIR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PLoS One 8: e64273, 2013.
43. Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, et al: Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23: 186-199, 2013.
44. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM and Albers AE: Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 6: e16466, 2011.
45. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
46. Burg MA, Tillet E, Timpl R and Stallcup WB: Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J Biol Chem 271: 26110-26116, 1996.
47. Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ and Pavlidis N: Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: Their prognostic value and role in tumour invasion and progression. Eur J Cancer 38: 2362-2370, 2002.
48. Huang Y, Chuang A, Hao H, Talbot C, Sen T, Trink B, Sidransky D and Ratovitski E: Phospho-Np63 is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ 18: 1220-1230, 2011.
49. Chung J, Lau J, Cheng LS, Grant RI, Robinson F, Ketela T, Reis PP, Roche O, Kamel-Reid S, Moffat J, et al: SATB2 augmentsNp63 in head and neck squamous cell carcinoma. EMBO Rep 11: 777-783, 2010.
50. Fomenkov A, Zangen R, Huang Y-P, Osada M, Guo Z, Fomenkov T, Trink B, Sidransky D and Ratovitski EA: RACK1 and stratifin targetNp63 for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 3: 1285-1295, 2004.
51. Donley N and Thayer MJ: DNA replication timing, genome stability and cancer: Late and/or delayed DNA replication timing is associated with increased genomic instability. Semin Cancer Biol 23: 80-89, 2013.
52. Suzuki M and Takahashi T: Aberrant DNA replication in cancer. Mutat Res 743-744: 111-117, 2013.
53. Lee J-K and Hurwitz J: Processive DNA helicase activity of the minichromosome maintenance proteins 4, 6, and 7 complex requires forked DNA structures. Proc Natl Acad Sci USA 98: 54-59, 2001.
54. Chatrath P, Scott IS, Morris LS, Davies RJ, Rushbrook SM, Bird K, Vowler SL, Grant JW, Saeed IT, Howard D, et al: Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer 89: 1048-1054, 2003.
55. Strati K, Pitot HC and Lambert PF: Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci USA 103: 14152-14157, 2006.